Tainted Skin-lightening Creams of Personal Care Brands Show Alarming Health Issues in Individuals

Unique mercury poisoning cases are creating revenue streams for healthcare companies in the mercury poisoning treatment market. For instance, in December 2019, it was reported that a women entered into comatose after using a skin-lightening cream of a world-renowned personal care brand, which was tainted with high levels of mercury. Such cases are increasing the demand for drugs induced with chelating agents and combination therapies in the mercury poisoning treatment market. As such, the market for mercury poisoning treatment is projected to expand at a favorable CAGR of ~5% during the forecast period.

Other key market drivers such as increased level of mercury emissions are fueling the demand for treatments involving combination therapy with chelating agents in the market for mercury poisoning treatment. It has been found that over the past several hundred years, mining and other human activities have released several million tons of mercury in the environment. Researchers at the David Streets of Argonne National Laboratory, U.S., stated that several pollutants, including mercury have not been sequestered naturally, and hence remain mobile in the environment causing new cases of mercury poisoning among individuals.

mercury poisoning treatment market infographic

To know the scope of our report Get a Sample on Mercury Poisoning Treatment Market 

Reinvestigation of Species Activities Surge in Mercury Poisoning Treatment Market

Researchers are using state-of-the-art methods to reinvestigate the historic Minamata mass mercury poisoning incident. For instance, researchers at the University of Saskatchewan (USask) are using novel techniques to study historic animal brain tissue samples to understand how mercury acts in the environment and affects humans. This is evident since individuals are prone to risks of exposure to mercury by the consumption of shellfish and fish items such as the Japanese delicacy Sushi.

Get a glimpse of the in-depth analysis through our Report Brochure

Activities such as reassessment of species involved in other organic mercury poisoning incidents, such as in Grassy Narrows, Ontario, are surging in the mercury poisoning treatment market. This explains why the revenue of organic mercury poisoning dictates the highest share among all forms in the market for mercury poisoning treatment. The high incidence of impaired peripheral vision and muscle weakness due to mercury exposure are creating revenue opportunities for companies in the market for mercury poisoning treatment.

Mercury-free Alternatives for Dental Fillings Generate Value-grab Opportunities for Practitioners

The high incidences of mercury poisoning are reported due to dental amalgams. These amalgams are traditionally made of a mix of mercury and a metal alloy that contains copper, silver or tin, which are used to fill dental cavities. Hence, scientists in the mercury poisoning treatment market are introducing mercury-free alternatives for fillings in order to reduce incidence of mercury exposure. Such innovative trends are boosting the revenue of the mercury poisoning treatment market, which is estimated to reach a value of ~US$ 50 Mn by the end of 2030.

Companies in the market for mercury poisoning treatment should collaborate with scientists to innovate in mercury-free alternatives for dental fillings. However, these alternative fillings are more expensive than traditional amalgams, which restricts its wide scale adoption in dental care settings. Hence, dental care practitioners in the market for mercury poisoning treatment are gaining efficacy in ultrasound, laser, and drug-based treatments to stimulate the regeneration of dentine.

Constant Contact with Federal Agencies Helps Anticipate Uncertainties amidst COVID-19 Pandemic

Healthcare systems worldwide are prepared to evaluate and care for patients with COVID-19 (coronavirus) or are suspected to contact the novel virus. Since mercury emissions are already prevalent in the environment, hospitals are in daily contact with local, state, and federal agencies in order to stay uncompromised when situation arises to treat patients with mercury poisoning. Hospitals in the market for mercury poisoning treatment are adopting safety practices in situations where patients require emergency care.

Companies in the mercury poisoning treatment market are increasing their production capabilities in drugs such as chelating agents to avoid any shortages in medical supplies. They are placing a skeleton crew to organize these production activities. Manufacturers are increasing the availability of mercury-free alternatives for dental fillings in case of pediatric dental care emergency cases.

mercury poisoning treatment market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Companies in the mercury poisoning treatment market are increasing the availability of drugs, especially involving chelating agents to meet emergency case requirements of individuals exposed to mercury amidst the COVID-19 outbreak. Researchers are leveraging their reinvestigation activities of historic animal species with the help of spectroscopy and sophisticated computational methods.

Mercury-free alternatives for dental fillings such as composite fillings, glass ionomer fillings, and gold inlays are creating revenue streams for dental practitioners. However, these alternatives are more expensive than traditional dental amalgams. Hence, healthcare companies should increase awareness about drug-based treatments and laser therapies that offset the risks involved with mercury poisoning.

Mercury Poisoning Treatment Market: Overview

  • According to Transparency Market Research’s latest research report on the global mercury poisoning treatment market for the historical period (2018–2019) and the forecast period (2020–2030), increase in disorders due to mercury is projected to drive the global mercury poisoning treatment market in the near future
  • According to the report, the global mercury poisoning treatment market was valued at ~US$ 32 Mn in 2019 and is anticipated to expand at a CAGR of ~5% from 2020 to 2030

Increase in Disorders due to Mercury to Drive Global Market

  • Human exposure to methylmercury (MeHg) is primarily due to intake of contaminated fish and seafood, which have been exposed to mercury through ingestion of contaminated lower organisms
  • According to the World Health Organization (WHO), methylmercury is toxic to the peripheral and central nervous systems. Inhaled mercury vapor can have harmful effects on the digestive, nervous, and immune systems, lungs, and kidneys.
  • The gastrointestinal tract absorbs about 95% of ingested MeHg. It enters the red blood cells and the brain by binding covalently to cysteine protein groups and glutathione.
  • Neurological conditions such as seizures, memory loss, mental retardation, language disorders, hearing loss, vision, and delayed development are the effects of mercury poisoning. In children, a syndrome characterized by painful and red extremities called acrodynia is caused due to chronic mercury exposure.

Rise in Usage of Dental Amalgams Propels Global Market

  • Amalgam has been used in dentistry for around 150 years. It is still being used due to low cost, ease of strength, bacteriostatic effect, application, and durability. Primary exposure to mercury from dental amalgam occurs during removal and placement of restoration in the tooth. Symptoms of amalgam allergy include skin rashes in the neck and head area, swollen lips, and itching.
  • Usage of amalgam is decreasing due to environmental pollution, detrimental health effects, and esthetics. Modern amalgams are made of precapsulated (preproportioned) alloy, including 42% to 45% mercury in weight. This could cause psychological and neurological disorders such as Alzheimer’s disease and Parkinson’s.
  • According to the WHO, dental amalgam is a significant source of exposure, as it can contain up to 50% elemental mercury. It releases fine particles or ions of mercury, which could be ingested or inhaled. Amalgam could represent an occupational risk for dentists. It could cause release of mercury into the atmosphere during cremation.

Limited Availability of Treatment to Hamper Global Market

  • Treatment of mercury toxicity i.e., poisoning, is quite limited. Treatments available are DMSA, 2,3-dimercaptosuccinic acid, British anti-lewisite (BAL) or dimercaprol, and dimercaptopropanesulfoxid acid (DMPS). These are currently used as chelating agents in mercury poisoning.
  • Evaluation of mercury exposure and toxicity is less due to limited laboratory testing
  • According to the WHO, drugs are utilized in a limited amount. The WHO has set the standards of intake of these drugs.
  • Mercury poisoning treatment drugs are under clinical trials. For instance, Emeramide is an exceptionally safe antidote for heavy metal poisoning and a powerful antioxidant. It is currently under the European Medical Agency (EMA) and the United States Food and Drug Administration (FDA) drug approval process. The manufacturer of Emeramide is EmeraMed.

Mercury Poisoning Treatment Market: Competition Landscape

  • This report profiles major players operating in the global mercury poisoning treatment market based on attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global mercury poisoning treatment market is moderately fragmented, with the presence of a few large players in the international market and numerous small players in regional markets. The top players hold major share of the global mercury poisoning treatment market.
  • Prominent players operating in the global mercury poisoning treatment market include 
    • Mylan N.V.
    • Akorn
    • Incorporated
    • EmeraMed
    • Sanofi,
    • Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG
    • Genex Pharma
  • Recordati S.p.A. (Recordati Rare Diseases)
  • The report on the global mercury poisoning treatment market discusses individual strategies, followed by company profiles of manufacturers of mercury poisoning treatment. The ‘competition landscape’ section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global mercury poisoning treatment market.

Mercury Poisoning Treatment Market – Segmentation

Drug

Chelating Agents

  • Dimercaprol or British anti-Lewisite (BAL)
  • Dimercaptosuccinic Acid (DMSA)
  • DMPS
  • Penicillamine
  • Others

Combination Therapy with Chelating Agents

Plasma Exchange Hemodialysis Plasmapheresis

Type

Acute Mercury Poisoning

Chronic Mercury Poisoning

Treatment Type

Supportive Treatment

Antidotal Treatment

Form

Inorganic Mercury

Elemental Mercury

Organic Mercury

Route of Administration

Injectable

Oral

Distribution Channel

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

The global mercury poisoning treatment market was worth US$ 32 Mn and is projected to reach a value of US$ 50 Mn by the end of 2030

Mercury poisoning treatment market is anticipated to grow at a CAGR of 5% during the forecast period

North America accounted for a major share of the global mercury poisoning treatment market

Mercury poisoning treatment market is driven by increased level of mercury emissions are fueling the demand for treatments involving combination therapy with chelating agents in the market for mercury poisoning treatment

Key players in the global mercury poisoning treatment market include Mylan N.V., Akorn, Incorporated, EmeraMed, Sanofi, Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG, Genex Pharma, and Recordati S.p.A. (Recordati Rare Diseases).

1. Preface 

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mercury Poisoning Treatment Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Mercury Poisoning Treatment Market Analysis and Forecast, 2018–2030

5. Market Outlook

    5.1. Mercury Poisoning Overview

    5.2. Research and Development Strategies & Pipeline Analysis

    5.3. Treatment Cost - Global - By Key Regions

    5.4. Drug Prices – Global - By Key Regions

    5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis 

6. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug 

    6.1. Introduction & Definition 

    6.2. Global Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

        6.2.1. Chelating Agents

            6.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

            6.2.1.2. Dimercaptosuccinic Acid (DMSA)

            6.2.1.3. DMPS

            6.2.1.4. Penicillamine

            6.2.1.5. Others

        6.2.2. Combination Therapy with Chelating Agents

        6.2.3. Plasma Exchange Hemodialysis Plasmapheresis

    6.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug

7. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type

    7.1. Introduction & Definition 

    7.2. Global Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

        7.2.1. Acute Mercury Poisoning

        7.2.2. Chronic Mercury Poisoning 

    7.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Type

8. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type

    8.1. Introduction 

    8.2. Global Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

        8.2.1. Supportive Treatment

        8.2.2. Antidotal Treatment

    8.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type

9. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form

    9.1. Introduction 

    9.2. Global Mercury Poisoning Treatment Market Value Forecast, by Form, 2018–2030

        9.2.1. Inorganic Mercury

        9.2.2. Elemental Mercury

        9.2.3. Organic Mercury

    9.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Form

10. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration

    10.1. Introduction 

    10.2. Global Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

        10.2.1. Injectable

        10.2.2. Oral

    10.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration

11. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel

    11.1. Introduction 

    11.2. Global Mercury Poisoning Treatment Market Value Forecast, by End-user, 2018–2030

        11.2.1. Hospital Pharmacies

        11.2.2. Online Pharmacies

        11.2.3. Retail Pharmacies

    11.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by End-user

12. Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region

    12.1. Introduction 

    12.2. Global Mercury Poisoning Treatment Market Value Forecast, by Region, 2018–2030

        12.2.1. North America

        12.2.2. Europe

        12.2.3. Asia Pacific

        12.2.4. Latin America

        12.2.5. Middle East & Africa

    12.3. Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Region

13. North America Mercury Poisoning Treatment Market Analysis and Forecast 

    13.1. Introduction

    13.2. North America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

        13.2.1. Chelating Agents

            13.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

            13.2.1.2. Dimercaptosuccinic Acid (DMSA)

            13.2.1.3. DMPS

            13.2.1.4. Penicillamine

            13.2.1.5. Others

        13.2.2. Combination Therapy with Chelating Agents

        13.2.3. Plasma Exchange Hemodialysis Plasmapheresis

    13.3. North America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

        13.3.1. Acute Mercury Poisoning

        13.3.2. Chronic Mercury Poisoning

    13.4. North America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

        13.4.1. Supportive Treatment

        13.4.2. Antidotal Treatment

    13.5. North America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

        13.5.1. Inorganic Mercury

        13.5.2. Elemental Mercury

        13.5.3. Organic Mercury

    13.6. North America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

        13.6.1. Injectable

        13.6.2. Oral

    13.7. North America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

        13.7.1. Hospital Pharmacies

        13.7.2. Online Pharmacies

        13.7.3. Retail Pharmacies

    13.8. North America Mercury Poisoning Treatment Market Value Forecast, by Country, 2018–2030

        13.8.1. U.S.

        13.8.2. Canada

    13.9. North America Mercury Poisoning Treatment Market Attractiveness Analysis

        13.9.1. By Drug

        13.9.2. By Type

        13.9.3. By Treatment Type

        13.9.4. By Form

        13.9.5. By Route of Administration

        13.9.6. By Distribution Channel

        13.9.7. By Country

14. Europe Mercury Poisoning Treatment Market Analysis and Forecast 

    14.1. Introduction

    14.2. Europe Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

        14.2.1. Chelating Agents

            14.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

            14.2.1.2. Dimercaptosuccinic Acid (DMSA)

            14.2.1.3. DMPS

            14.2.1.4. Penicillamine

            14.2.1.5. Others

        14.2.2. Combination Therapy with Chelating Agents

        14.2.3. Plasma Exchange Hemodialysis Plasmapheresis

    14.3. Europe Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

        14.3.1. Acute Mercury Poisoning

        14.3.2. Chronic Mercury Poisoning

    14.4. Europe Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

        14.4.1. Supportive Treatment

        14.4.2. Antidotal Treatment

    14.5. Europe Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

        14.5.1. Inorganic Mercury

        14.5.2. Elemental Mercury

        14.5.3. Organic Mercury

    14.6. Europe Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

        14.6.1. Injectable

        14.6.2. Oral

    14.7. Europe Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

        14.7.1. Hospital Pharmacies

        14.7.2. Online Pharmacies

        14.7.3. Retail Pharmacies

    14.8. Europe Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

        14.8.1. Germany

        14.8.2. U.K.

        14.8.3. France

        14.8.4. Spain

        14.8.5. Italy 

        14.8.6. Rest of Europe

    14.9. Europe Mercury Poisoning Treatment Market Attractiveness Analysis

        14.9.1. By Drug

        14.9.2. By Type

        14.9.3. By Treatment Type

        14.9.4. By Form

        14.9.5. By Route of Administration

        14.9.6. By Distribution Channel

        14.9.7. By Country/Sub-region

15. Asia Pacific Mercury Poisoning Treatment Market Analysis and Forecast 

    15.1. Introduction

    15.2. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

        15.2.1. Chelating Agents

            15.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

            15.2.1.2. Dimercaptosuccinic Acid (DMSA)

            15.2.1.3. DMPS

            15.2.1.4. Penicillamine

            15.2.1.5. Others

        15.2.2. Combination Therapy with Chelating Agents

        15.2.3. Plasma Exchange Hemodialysis Plasmapheresis

    15.3. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

        15.3.1. Acute Mercury Poisoning

        15.3.2. Chronic Mercury Poisoning

    15.4. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

        15.4.1. Supportive Treatment

        15.4.2. Antidotal Treatment

    15.5. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

        15.5.1. Inorganic Mercury

        15.5.2. Elemental Mercury

        15.5.3. Organic Mercury

    15.6. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

        15.6.1. Injectable

        15.6.2. Oral

    15.7. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

        15.7.1. Hospital Pharmacies

        15.7.2. Online Pharmacies

        15.7.3. Retail Pharmacies

    15.8. Asia Pacific Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

        15.8.1. Japan

        15.8.2. China

        15.8.3. India

        15.8.4. Australia & New Zealand

        15.8.5. Rest of Asia Pacific

    15.9. Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis

        15.9.1. By Drug

        15.9.2. By Type

        15.9.3. By Treatment Type

        15.9.4. By Form

        15.9.5. By Route of Administration

        15.9.6. By Distribution Channel

        15.9.7. By Country/Sub-region

16. Latin America Mercury Poisoning Treatment Market Analysis and Forecast 

    16.1. Introduction

    16.2. Latin America Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

        16.2.1. Chelating Agents

            16.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

            16.2.1.2. Dimercaptosuccinic Acid (DMSA)

            16.2.1.3. DMPS

            16.2.1.4. Penicillamine

            16.2.1.5. Others

        16.2.2. Combination Therapy with Chelating Agents

        16.2.3. Plasma Exchange Hemodialysis Plasmapheresis

    16.3. Latin America Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

        16.3.1. Acute Mercury Poisoning

        16.3.2. Chronic Mercury Poisoning

    16.4. Latin America Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

        16.4.1. Supportive Treatment

        16.4.2. Antidotal Treatment

    16.5. Latin America Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

        16.5.1. Inorganic Mercury

        16.5.2. Elemental Mercury

        16.5.3. Organic Mercury

    16.6. Latin America Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

        16.6.1. Injectable

        16.6.2. Oral

    16.7. Latin America Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

        16.7.1. Hospital Pharmacies

        16.7.2. Online Pharmacies

        16.7.3. Retail Pharmacies

    16.8. Latin America Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

        16.8.1. Brazil

        16.8.2. Mexico

        16.8.3. Rest of Latin America

    16.9. Latin America Mercury Poisoning Treatment Market Attractiveness Analysis

        16.9.1. By Drug

        16.9.2. By Type

        16.9.3. By Treatment Type

        16.9.4. By Form

        16.9.5. By Route of Administration

        16.9.6. By Distribution Channel

        16.9.7. By Country/Sub-region

17. Middle East & Africa Mercury Poisoning Treatment Market Analysis and Forecast 

    17.1. Introduction

    17.2. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Drug, 2018–2030

        17.2.1. Chelating Agents

            17.2.1.1. Dimercaprol or British anti-Lewisite (BAL)

            17.2.1.2. Dimercaptosuccinic Acid (DMSA)

            17.2.1.3. DMPS

            17.2.1.4. Penicillamine

            17.2.1.5. Others

        17.2.2. Combination Therapy with Chelating Agents

        17.2.3. Plasma Exchange Hemodialysis Plasmapheresis

    17.3. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Type, 2018–2030

        17.3.1. Acute Mercury Poisoning

        17.3.2. Chronic Mercury Poisoning

    17.4. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Treatment Type, 2018–2030

        17.4.1. Supportive Treatment

        17.4.2. Antidotal Treatment

    17.5. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Form 2018–2030

        17.5.1. Inorganic Mercury

        17.5.2. Elemental Mercury

        17.5.3. Organic Mercury

    17.6. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Route of Administration, 2018–2030

        17.6.1. Injectable

        17.6.2. Oral

    17.7. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Distribution Channel, 2018–2030

        17.7.1. Hospital Pharmacies

        17.7.2. Online Pharmacies

        17.7.3. Retail Pharmacies

    17.8. Middle East & Africa Mercury Poisoning Treatment Market Value Forecast, by Country/Sub-region, 2018–2030

        17.8.1. GCC Countries

        17.8.2. South Africa

        17.8.3. Rest of Middle East & Africa

    17.9. Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis

        17.9.1. By Drug

        17.9.2. By Type

        17.9.3. By Treatment Type

        17.9.4. By Form

        17.9.5. By Route of Administration

        17.9.6. By Distribution Channel

        17.9.7. By Country/Sub-region

18. Competition Landscape

    18.1. Market Player - Competition Matrix (By Tier and Size of companies)

    18.2. Global Mercury Poisoning Treatment Market Position Analysis, by Company, 2019

    18.3.  Company Profiles

        18.3.1. Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG 

            18.3.1.1. Company Description

            18.3.1.2. Business Overview

            18.3.1.3. Strategic Overview

            18.3.1.4. SWOT Analysis

        18.3.2. Genex Pharma 

            18.3.2.1. Company Description

            18.3.2.2. Business Overview

            18.3.2.3. Strategic Overview

            18.3.2.4. SWOT Analysis

        18.3.3. RECORDATI S.p.A. (Recordati Rare Diseases) 

            18.3.3.1. Company Description

            18.3.3.2. Business Overview

            18.3.3.3. Financial Overview

            18.3.3.4. Strategic Overview

            18.3.3.5. SWOT Analysis

        18.3.4. Mylan N.V. 

            18.3.4.1. Company Description

            18.3.4.2. Business Overview

            18.3.4.3. Strategic Overview

            18.3.4.4. Financial Overview

            18.3.4.5. SWOT Analysis

        18.3.5. Akorn, Incorporated 

            18.3.5.1. Company Description

            18.3.5.2. Business Overview

            18.3.5.3. Strategic Overview

            18.3.5.4. Financial Overview

            18.3.5.5. SWOT Analysis

        18.3.6. EmeraMed Limited 

            18.3.6.1. Company Description

            18.3.6.2. Business Overview

            18.3.6.3. SWOT Analysis

        18.3.7. Sanofi

            18.3.7.1. Company Description

            18.3.7.2. Business Overview

            18.3.7.3. Strategic Overview

            18.3.7.4. SWOT Analysis

List of Tables

Table 01 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 02 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 03 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 04 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type 2018–2030

Table 05 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 06 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 07 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 08 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 11 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 12 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 13 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 14 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 15 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 16 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 17 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 19 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 20 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 21 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 22 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 23 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 24 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 25 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 27 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 28 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 29 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 30 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 31 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 32 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 33 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 35 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 36 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 37 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 38 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 39 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 40 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 41 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Drug, 2018–2030

Table 43 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Chelating Agents, 2018–2030

Table 44 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 45 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 46 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Form, 2018–2030

Table 47 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 48 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figures

Figure 01 Global Mercury Poisoning Treatment Market Size (US$ Mn) Forecast, 2018–2030

Figure 02 Global Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030

Figure 03 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030

Figure 04 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chelating Agents, 2018–2030

Figure 05 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Combination Therapy with Chelating Agents, 2018–2030

Figure 06 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Plasma Exchange Hemodialysis Plasmapheresis, 2018–2030

Figure 07 Global Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 08 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 09 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Acute Mercury Poisoning, 2018–2030

Figure 10 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chronic Mercury Poisoning, 2018–2030

Figure 11 Global Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 12 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 13 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Supportive Treatment, 2018–2030

Figure 14 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Antidotal Treatment, 2018–2030

Figure 15 Global Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030

Figure 16 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030

Figure 17 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Inorganic Mercury, 2018–2030

Figure 18 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Elemental Mercury, 2018–2030

Figure 19 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Organic Mercury, 2018–2030

Figure 20 Global Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 21 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 22 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Injectable, 2018–2030

Figure 23 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Oral, 2018–2030

Figure 24 Global Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 25 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 26 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030

Figure 27 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Online Pharmacies, 2018–2030

Figure 28 Global Mercury Poisoning Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030

Figure 29 Global Mercury Poisoning Treatment Market Value Share Analysis, by Region, 2019 and 2030

Figure 30 Global Mercury Poisoning Treatment Market Attractiveness Analysis, by Region, 2020–2030

Figure 31 North America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 32 North America Mercury Poisoning Treatment Market Value Share Analysis, by Country, 2019 and 2027

Figure 33 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Country, 2020–2030

Figure 34 North America Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030

Figure 35 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030

Figure 36 North America Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 37 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 38 North America Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 39 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 40 North America Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030

Figure 41 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030

Figure 42 North America Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 43 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 44 North America Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 45 North America Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 46 Europe Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 47 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 48 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 49 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030

Figure 50 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030

Figure 51 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 52 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 53 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 54 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 55 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030

Figure 56 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030

Figure 57 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 58 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 59 Europe Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 60 Europe Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 61 Asia Pacific Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 62 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 63 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 64 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030

Figure 65 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030

Figure 66 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 67 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 68 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 69 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 70 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030

Figure 71 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030

Figure 72 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 73 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 74 Asia Pacific Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 75 Asia Pacific Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 76 Latin America Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 77 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 78 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 79 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030

Figure 80 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030

Figure 81 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 82 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 83 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 84 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 85 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030

Figure 86 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030

Figure 87 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 88 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 89 Latin America Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 90 Latin America Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 91 Middle East & Africa Mercury Poisoning Treatment Market Value (US$ Mn) Forecast, 2018–2030

Figure 92 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027

Figure 93 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 94 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Drug, 2019 and 2030

Figure 95 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Drug, 2020–2030

Figure 96 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Type, 2019 and 2030

Figure 97 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Type, 2020–2030

Figure 98 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 99 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 100 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Form, 2019 and 2030

Figure 101 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Form, 2020–2030

Figure 102 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 103 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 104 Middle East & Africa Mercury Poisoning Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 105 Middle East & Africa Mercury Poisoning Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Mercury Poisoning Treatment Market